Literature DB >> 24486410

Heparan sulfate proteoglycans and heparin regulate melanoma cell functions.

D Nikitovic1, M Mytilinaiou1, Ai Berdiaki1, N K Karamanos2, G N Tzanakakis3.   

Abstract

BACKGROUND: The solid melanoma tumor consists of transformed melanoma cells, and the associated stromal cells including fibroblasts, endothelial cells, immune cells, as well as, soluble macro- and micro-molecules of the extracellular matrix (ECM) forming the complex network of the tumor microenvironment. Heparan sulfate proteoglycans (HSPGs) are an important component of the melanoma tumor ECM. Importantly, there appears to be both a quantitative and a qualitative shift in the content of HSPGs, in parallel to the nevi-radial growth phase-vertical growth phase melanoma progression. Moreover, these changes in HSPG expression are correlated to modulations of key melanoma cell functions. SCOPE OF REVIEW: This review will critically discuss the roles of HSPGs/heparin in melanoma development and progression. MAJOR
CONCLUSIONS: We have correlated HSPGs' expression and distribution with melanoma cell signaling and functions as well as angiogenesis. GENERAL SIGNIFICANCE: The current knowledge of HSPGs/heparin biology in melanoma provides a foundation we can utilize in the ongoing search for new approaches in designing anti-tumor therapy. This article is part of a Special Issue entitled Matrix-mediated cell behaviour and properties.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell function; Heparan sulfate proteoglycan; Heparin; Melanoma

Mesh:

Substances:

Year:  2014        PMID: 24486410     DOI: 10.1016/j.bbagen.2014.01.031

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  Demystifying the pH dependent conformational changes of human heparanase pertaining to structure-function relationships: an in silico approach.

Authors:  Hemavathy Nagarajan; Umashankar Vetrivel
Journal:  J Comput Aided Mol Des       Date:  2018-07-06       Impact factor: 3.686

Review 2.  Melanocytic nevi and melanoma: unraveling a complex relationship.

Authors:  W E Damsky; M Bosenberg
Journal:  Oncogene       Date:  2017-06-12       Impact factor: 9.867

3.  Human melanoma inhibitory protein binds to the FN12-14 Hep II domain of fibronectin.

Authors:  King Tuo Yip; Xueyin Zhong; Nadia Seibel; Oliver Arnolds; Miriam Schöpel; Raphael Stoll
Journal:  Biointerphases       Date:  2017-05-31       Impact factor: 2.456

4.  Inhibition effect of a custom peptide on lung tumors.

Authors:  Chih-Yu Huang; Hsuan-Yu Huang; Michael D Forrest; Yun-Ru Pan; Wei-Jen Wu; Hueih-Min Chen
Journal:  PLoS One       Date:  2014-10-13       Impact factor: 3.240

Review 5.  The motile breast cancer phenotype roles of proteoglycans/glycosaminoglycans.

Authors:  Dragana Nikitovic; Katerina Kouvidi; Kallirroi Voudouri; Aikaterini Berdiaki; Evgenia Karousou; Alberto Passi; George N Tzanakakis
Journal:  Biomed Res Int       Date:  2014-07-22       Impact factor: 3.411

6.  Human telomerase reverse transcriptase (hTERT) promotes gastric cancer invasion through cooperating with c-Myc to upregulate heparanase expression.

Authors:  Bo Tang; Rui Xie; Yong Qin; Yu-Feng Xiao; Xin Yong; Lei Zheng; Hui Dong; Shi-Ming Yang
Journal:  Oncotarget       Date:  2016-03-08

7.  Human sulfatase 1 exerts anti-tumor activity by inhibiting the AKT/ CDK4 signaling pathway in melanoma.

Authors:  Xiaoli Lou; Bin Sun; Jianxing Song; Yicun Wang; Junhao Jiang; Yang Xu; Zeqiang Ren; Changqing Su
Journal:  Oncotarget       Date:  2016-12-20

Review 8.  Syndecan receptors: pericellular regulators in development and inflammatory disease.

Authors:  Sandeep Gopal; Samantha Arokiasamy; Csilla Pataki; James R Whiteford; John R Couchman
Journal:  Open Biol       Date:  2021-02-10       Impact factor: 6.411

9.  Variations in the expression of TIMP1, TIMP2 and TIMP3 in cutaneous melanoma with regression and their possible function as prognostic predictors.

Authors:  Sabina Zurac; Monica Neagu; Carolina Constantin; Mirela Cioplea; Roxana Nedelcu; Alexandra Bastian; Cristiana Popp; Luciana Nichita; Razvan Andrei; Tiberiu Tebeica; Cristiana Tanase; Virginia Chitu; Constantin Caruntu; Mihaela Ghita; Catalin Popescu; Daniel Boda; Bogdan Mastalier; Nicoleta Maru; Claudiu Daha; Bogdan Andreescu; Ioan Marinescu; Adrian Rebosapca; Florica Staniceanu; Gabriela Negroiu; Daniela A Ion; Dragana Nikitovic; George N Tzanakakis; Demetrios A Spandidos; Aristidis M Tsatsakis
Journal:  Oncol Lett       Date:  2016-03-29       Impact factor: 2.967

Review 10.  Proteoglycans-Biomarkers and Targets in Cancer Therapy.

Authors:  Dragana Nikitovic; Aikaterini Berdiaki; Ioanna Spyridaki; Theodoros Krasanakis; Aristidis Tsatsakis; George N Tzanakakis
Journal:  Front Endocrinol (Lausanne)       Date:  2018-03-06       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.